ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

In Brief: CCIRC Recommends Central Oncology Group For Phasing Out; Rogers Backs Pay Raise

March 5, 1976

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

NCI Supercomputer To Be Available To Extramural Scientists

June 8, 1984

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998